Osteolysis due to wear of the bearing surface has been identified as the leading cause of longterm failure in patients who undergo metal-onpolyethylene total hip arthroplasty (THA). 1, 2 Polyethylene (PE) wear is associated with its manufacturing process, and factors related to the patient. During the past two decades, advancements in PE manufacturing, namely PE crosslinking, have led to a dramatic decrease in the number of revision procedures due to periprosthetic osteolysis caused by particulate PE debris. 3, 4 Crosslinking is achieved by irradiating PE at a dose higher than is required for sterilization, which is of approximately 25 kGy. 5 This process induces the formation of covalent bonds between the polymer chains of PE (crosslinks), which result in increased resistance to wear. 6 However, the resulting polymer (radiation crosslinked PE) 
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Evaluation of in vivo wear of vitamin E-diffused highly crosslinked polyethylene at five years

Results
Conclusion
Five years postoperatively, patients with VEPE (vs ModXLPE) and ceramic (vs metal) femoral heads had decreased wear. The rates of wear for both liners were very low and have not led to any osteolysis or implant failure due to aseptic loosening. has a high free radical content and is therefore susceptible to oxidation, which renders it brittle with potentially decreased resistance to wear in the long term. The oxidative stability of PE may be increased by annealing, which reduces the free radical content at a temperature below the melting point of the material. 7 Annealing may be thermal (heating below the melting point) or mechanical (hydrostatic extrusion). Mechanical annealing involves deformation of the irradiated material at a constant temperature. This process increases the mobility of the radicals in the crystalline domains by crystal plasticity, thereby facilitating their recombination and resulting in further crosslinking. Annealing maintains the mechanical strength, but some free radicals remain trapped within the crystal domains of the material. 8 An alternative approach is chemical stabilization using a free radical scavenger, such as vitamin E (α-tocopherol). Vitamin E can be either blended into the PE before irradiation or diffused into a radiation crosslinked-PE.
9 Vitamin E prevents the propagation of the oxidation cascade, although the free radicals are still present. 10 Vitamin-E stabilization enhances the long-term oxidative resistance of crosslinked-PE while allowing it to retain its mechanical properties. [11] [12] [13] In 2007, vitamin E-diffused crosslinked-PE (VEPE) was cleared by the United States Food and Drug Administration (FDA) for clinical use in THA.
12 Currently, most major orthopaedic manufacturers have a variation of VEPE on the market, 11 and the early results of VEPE in THA have been promising.
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The primary aim of this study was to evaluate and compare the wear properties of VEPE with one formulation of moderately crosslinked and mechanically annealed ultra-high molecular weight PE (ModXLPE) using radiostereometric analysis (RSA) in patients five years after primary THA. The secondary aim was to assess the clinical results of patients treated with VEPE using patient-reported outcome measures (PROMs), radiological evidence of fixation, and the incidence of mechanical failure.
Patients and Methods
A total of 208 patients from four international centres who underwent 221 THAs for primary osteoarthritis were recruited into a prospective RSA and clinical outcomes study (Table I) . Patients were included if they were aged between 20 and 75 years. Exclusion criteria were inflammatory arthritis, prior steroid or chemotherapy treatment, osteoporosis, and osteomalacia. All data were anonymized and uploaded to an academic coordinating research organization (ACRO) via secure online transfer by the participating centres. The study had ethical approval from each centre and was registered with Clinical Trials.gov (NCT00551967). All patients gave informed consent. A total of 193 hips (87%) were reviewed five years postoperatively and had their data uploaded to the ACRO. Acetabular components. The THAs were performed with implants from a single manufacturer (Zimmer Biomet, Warsaw, Indiana). A total of 136 (70%) hips received highly crosslinked (95 kGy) VEPE liners (E1); the remaining hips received moderately crosslinked (50 kGy) (ModXLPE), mechanically annealed liners (ArCom XL). The stages involved in the production of GmbH, Plochingen, Germany). Of the 12 36 mm heads, seven were metal and five were ceramic. The choice of femoral head was at the surgeon's discretion, as was the design of the stem. One of two proximally coated, uncemented Zimmer Biomet stems were used: Taperloc or Bimetric. The operations were performed by a total of 14 surgeons across the four centres using either the anterolateral or posterolateral approach according to the preference of the surgeon. A summary of the variables is shown in Table II . Clinical follow-up data and analysis. PROMs and plain anteroposterior radiographs were collected preoperatively and postoperatively at one-, two-, and five-year intervals. Function was assessed using the Harris Hip Score 17 and the Physical Function sub-score of the Short Form Health Survey (SF-36). 18 The average pain experienced during the month prior to the THA (0, no pain; 10, worst imaginable) and satisfaction with the procedure (0, very satisfied; 10, dissatisfied) were assessed using a visual analogue scale (VAS). Overall health-related quality of life was assessed using the EuroQol five-dimension, three-level (EQ-5D-3L) index.
19
The position of the components postoperatively was analyzed using the Hip Analysis Suite software (University of Chicago, Chicago, Illinois) (Martell method). 20 Radiolucency and osteolysis around the shell were assessed postoperatively and at the five-year follow-up by three validated orthopaedic surgeons at the ACRO, each with at least four years of experience analyzing radiographs. Inter-observer reliability was high (κ > 0.9). Radiolucencies were measured using the mDesk software (RSA Biomedical, Umeå, Sweden). A radiolucent line measuring ≥ 0.5 mm in thickness was defined as a "gap". If such a line appeared for the first time at the five-year follow-up, it was defined as a "radiolucency" and if this was ≥ 2.0 mm thick it was classified as osteolysis. RSA. Wear of the PE was assessed on RSA images, taken postoperatively and at one-, two-, and five-year intervals. The images were taken with the patients in the supine position and the hip of interest centred within the uniplanar calibration cage (cage 43, RSA Biomedical). The UmRSA 6.0 software package (RSA Biomedical) was used to analyze displacement of the femoral head in the proximal-distal plane (femoral head penetration), which was considered the primary RSA metric in this study.
Model-based RSA was used in the primary analysis for the whole cohort. The software identified the centre of the femoral head using semi-automated edge-detection of the circumference of the head. The edge of the acetabular shell was similarly identified following manual detection of five points on its circumference. The precise orientation of the shell was then estimated by projecting the image of a model of the implant within the boundaries of the detected edge until minimal differences remained. At each follow-up, the position of the centre of the femoral head relative to the acetabular shell was compared with that of the position recorded at a previous postoperative interval. The movement of the femoral head in the proximal-distal plane was isolated from the 3D vector and served as a surrogate measurement of wear.
21
A sub-analysis was also undertaken using marker-based RSA on the patients from the centres who randomized their patients by the type of liner, as these centres also injected tantalum beads into the liners. For this analysis, the beads were identified in the software and used as the reference when assessing the penetration of the head.
Total wear is presented as the five-year penetration compared with the first postoperative film (less than six months from surgery), and the steady state wear rate was calculated by comparing the five-year penetration with the two-year penetration in order to account for the bedding-in period. Measurements of precision were made by all four centres using repeated examinations taken at two years. Precision was defined as the standard deviation of the difference between the repeated examinations, multiplied by the critical value (t), from a t distribution table. 22 The mean error (ME) of tolerance was set at 0.35 mm. Statistical analysis. Wilcoxon's signed-rank test was used to assess the change in wear for each liner group from the first to second and second to fifth postoperative year. Univariate analyses (Simple linear regression or Mann-Whitney U test) were used to identify factors associated with total wear at five years. Additionally, multivariate analysis was used to identify factors independently predictive of increased wear at five years. In addition to the type of liner, other factors that have been postulated to contribute to PE wear including acetabular inclination, anteversion, the size and material of the femoral head, the type of shell, and body mass index (BMI) were included in a linear regression. The backward elimination method was used to reach parsimony. In the sub-analysis of patients who were randomized by the type of liner, a similar model was created, using five-year wear derived from marker-based, instead of model-based, RSA as the dependent variable. A Mann-Whitney U test was used to assess the association between wear and the development of radiolucency five years postoperatively, and chi-squared analysis was used to test the association between the development of radiolucency five years postoperatively and the type of liner and shell. The differences in PROMs between the two liner groups were assessed using the Mann-Whitney U test and by linear regression, controlling for age and gender. Finally, analyses were performed to assess for possible differences between the centres in follow-up and demographics (Table I) . Statistical significance was set at p < 0.05. SPSS statistical software (IBM Corp., Armonk, New York) was used.
Results
Patients and descriptive data. The mean time to the five-year visit was 4.9 years (4.1 to 5.5). Six hips were revised prior to this time: four for recurrent dislocation, one for periprosthetic fracture, and one for infection. No hip was revised for aseptic loosening. The rate of implant survival was 97.1% (95% confidence interval (CI) 96.9% to 97.3%) at five years. Four patients died before the five-year follow-up, and eight withdrew consent, leaving ten (4.5%) who were lost to follow-up (Fig. 2) . Patient selection and follow-up proved comparable across the centres (Table I) . RSA. There was no significant increase between the measurements of total wear one and two years postoperatively for the VEPE (Wilcoxon's signed-rank test; p = 0.973) or the ModXLPE (Wilcoxon's signed-rank test; p = 0.557) cohorts, and there was no difference in total wear at two years between the different types of liner (Mann-Whitney U test; p = 0.579). However, at the five-year follow-up, the total femoral head penetration was significantly lower into VEPE liners (median 0.06 mm; interquartile range (IQR) 0.0 to 0.1) than into ModXLPE liners (median 0.13 mm; IQR 0.0 to 0.3) (MannWhitney U test; p < 0.001). The median penetration in the VEPE cohort did not increase between the two-and five-year follow-up visits (Wilcoxon's signed-rank test; p = 0.132). In contrast, there was a significant increase (median 0.04 mm/yr; IQR 0.00 to 0.06) in the penetration of the femoral head in the ModXLPE group (Wilcoxon's signed-rank test; p < 0.001) during this time (Fig. 3) . (Table III) . When the VEPE and ModXLPE cohorts were considered separately, a ceramic head was associated with decreased five-year total wear in both groups (VEPE, β = 0.12, p < 0.001; ModXLPE, β = 0.23, p < 0.001) ( Table IV) .
The median steady state rate of wear was 0.07 mm/yr (IQR 0.03 to 0.09) for patients with ModXLPE liners and metal femoral heads, compared with 0.02 mm/yr (IQR 0.00 to 0.06) for those with a ModXLPE-ceramic bearing (Mann-Whitney U test; p < 0.001). For the VEPE cohort, those with a metal femoral head had a steady state rate of wear of 0.02 mm/yr (IQR 0.01 to 0.03), compared with 0.00 mm/yr (IQR -0.02 to 0.02) for those with a ceramic femoral head (Mann-Whitney U test; p = 0.019). The ModXLPE-ceramic bearing had wear similar to the VEPE-metal (Mann-Whitney U test; p = 0.695) and VEPE-ceramic bearings (Mann-Whitney U test; p = 0.581).
A sub-analysis of the 131 patients from the two centres who were randomized by the type of liner and injected tantalum beads into the liners was conducted to confirm that the results were not skewed by selection or measurement bias. A total of 26 hips (20%) were treated with a ModXLPE liner and a metal femoral head, 31 (24%) with ModXLPE and ceramic, 37 (28%) with VEPE and metal and 37 (28%) with VEPE and ceramic. Total wear derived from marker-based RSA was tested in a linear model, in which a ModXLPE (vs VEPE) liner (multivariable linear model; β = 0.14, p = 0.042) and metal (vs ceramic) femoral head (multivariable linear model; β = 0.16, p = 0.005) were found to be predictive of increased five-year wear.
The mean ME for the cohort was low: 0.17 mm (sd 0.02). The repeated examinations indicated a high precision in the proximal-distal plane of 0.088 mm. A post hoc power analysis PROMs. There were no differences in PROMs between the liner groups, and there was no correlation between PE wear and the PROMs for the cohort. The clinical outcome five years postoperatively was excellent, and all patients had an excellent improvement from the postoperative status (Table V) .
Discussion
Since the first THAs that were developed by Charnley in the 1960s, a central goal has been to provide a strong articulation that minimizes the shedding of synthetic particulate debris into the periprosthetic space. The most significant step towards achieving this goal has been the development of crosslinked PE, first cleared by the FDA in 1998. Following ubiquitous evidence of its success, crosslinked PE has been used throughout the past decade for most THAs. 23 It is important to note, however, that the manufacturing process differs between crosslinked-PE formulations. Among other variables, these differences include the dose of radiation and the post-radiation treatment. These engineering differences yield trade-offs between wear and mechanical and oxidative resistance that have implications on their effectiveness. 24 In this multicentre, RSA study, we aimed to compare the five-year in vivo wear performance of two formulations of crosslinked-PE: VEPE and ModXLPE. We also sought to understand whether clinical or radiological outcomes are associated with wear.
We found that the VEPE and ModXLPE liners had similar bedding in and low wear during the first five postoperative years for all patients. VEPE, however, was found to be independently associated with both lower total wear at the five-year interval and a lower rate of wear between the two and five-year intervals when compared with ModXLPE. This difference was expected, as VEPE is treated with a higher dose of radiation than ModXLPE, resulting in a higher density of crosslinking of the former. Future follow-up and retrieval studies will elucidate the protective, antioxidative effects of vitamin E against long-term oxidation. In the ModXLPE cohort, the wear rates of 0.07 mm/yr with the metal head and 0.02 mm/yr observed with the ceramic head are both similar to those of some other formulations of highly crosslinked (100 kGy) PE. 25 We also found that ceramic femoral heads are independently protective against total and steady-state wear when compared with metal femoral heads. Although the rate of wear of PE has been shown to vary with the use of a metal or ceramic head in hip simulator 26 and in vivo studies with ultra-high-molecularweight polyethylenes (UHMWPE), 27, 28 this is the first clinical study to show a difference in moderately or highly crosslinked PE wear between metal and ceramic heads. This difference may be due to the increased wettability and scratch-resistance of the ceramic surface. In our regression model, the effect of the metal femoral head, with a mean of 0.21 mm more total wear than ceramic, was similar to the effect of ModXLPE, with a mean of 0.22 mm more total wear than VEPE. Although these effects are No other factor that we controlled for, including BMI, the positioning of the acetabular component, type of shell, and femoral head size, proved to be associated with the total wear five years postoperatively or the steady-state rate of wear. Another recent study found gender differences in wear for one formulation of highly crosslinked PE (Longevity; Zimmer Biomet) at five years, probably based on gender differences in the distribution of the sizes of the femoral head. 29 It is important to note that this study included only 28 mm and 32 mm ceramic heads. Therefore, comparisons with our study should be made with caution as we included 32 mm and 36 mm metal and ceramic heads. Furthermore, firm conclusions cannot be made regarding our observed null effect of head size, as only 12 patients (6.2%) in this cohort had 36 mm heads.
Even those patients with both risk factors for increased wear, ModXLPE liners and metal femoral heads, had median wear rates (0.07 mm/yr) below the threshold for osteolysis (0.1 mm/ yr). 2 This would explain why no patients in our cohort developed osteolysis. Although we found that 30 patients (15.5%) developed new radiolucencies at five years, there was no association between this development and wear or of any of the other implant or patient demographic factors, including a VEPE liner. There was also no relationship between the rate of wear and PROMs.
The current study is the largest analysis of vitamin E-diffused PE wear at five-year follow-up using the most sensitive and accurate technique for its measurement which is available: RSA. However, it had limitations. First, tantalum beads were not inserted into the liners at all the centres; we therefore measured wear by model-based RSA in our primary analysis. The marker-method has been shown to be the most precise, 22 although it has been argued that the increased precision is inconsequential. 15 Importantly, our sub-analysis of patients assessed by marker-based RSA confirmed the results of our primary analysis, showing a protective effect of VEPE and a ceramic femoral head against wear at five years. Second, the control group did not involve highly crosslinked PE. A highly crosslinked (100 kGy) PE undergoing a standard post-irradiation treatment (remelting or annealing) would have allowed us to isolate the antioxidative effects of vitamin E better. Finally, perfect randomization of type of liner was not achieved, as VEPE had become the standard of care by the time of the study at two of the four centres, and the material of the femoral head was not randomized by any of the centres. Concerns of selection bias are, however, lessened by our sub-analysis of patients randomized by type of liner and having a roughly uniform distribution of the four liner-head combinations.
In conclusion, we observed similar bedding in one year postoperatively and wear rate two years postoperatively between the two types of liner. However, there was a significantly higher rate of wear in the ModXLPE cohort compared with the VEPE cohort between two and five years postoperatively. There was higher total wear five years postoperatively for the ModXLPE cohort than for the VEPE cohort. A ceramic femoral head was also independently predictive of lower wear at five years for both types. It is important to note that the statistically significant differences in wear do not equate to a clinically important difference. Currently, the rates of wear for all patients are low and have not led to any osteolysis or failures due to aseptic loosening. Continued follow-up will provide a better understanding of the association between the rate of wear and clinical outcomes.
Take home message
-Vitamin E-diffiused, highly crosslinked polyethylene (VEPE) shows less wear than mechanically annealed ultra-highmolecular-weight polyethylene (ModXLPE) at five years.
-No osteolysis or other signs of wear were observed in the VEPE cohort. -A ceramic head was independently predictive of lower wear at five years.
-Patient-reported outcome measures did not differ between types of PE or femoral head.
